Adways Inc. Logo

Adways Inc.

Global mobile marketing firm providing ad tech and agency services, focused on Asian markets.

2489 | T

Overview

Corporate Details

ISIN(s):
JP3121970002
LEI:
Country:
Japan
Address:
新宿区西新宿五丁目1番1号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Adways Inc. is a global mobile marketing company headquartered in Tokyo, Japan. The firm specializes in internet and smartphone app advertising, providing clients with proprietary, top-class advertising technology and comprehensive agency services. Adways focuses on connecting advertisers with website and app operators, offering total mobile marketing solutions primarily for the Asian market, with an operational presence in China, Taiwan, Korea, the Philippines, and the United States. The company also engages in startup investments through its venture capital arm, Adways Ventures, Inc.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-13 07:30
Interim Report
半期報告書-第26期(2025/01/01-2025/12/31)
Japanese 214.4 KB
2025-08-13 07:30
Report Publication Announcement
確認書
Japanese 7.9 KB
2025-03-31 07:30
Regulatory News Service
臨時報告書
Japanese 17.9 KB
2025-03-27 06:33
Post-Annual General Meeting Information
臨時報告書
Japanese 24.3 KB
2025-03-27 06:32
Governance Information
内部統制報告書-第25期(2024/01/01-2024/12/31)
Japanese 22.1 KB
2025-03-27 06:31
Annual Report
有価証券報告書-第25期(2024/01/01-2024/12/31)
Japanese 1.3 MB
2025-03-27 06:31
Registration Form
確認書
Japanese 8.0 KB
2025-02-18 06:31
Regulatory News Service
臨時報告書
Japanese 19.7 KB
2025-02-18 06:30
Share Issue/Capital Change
臨時報告書
Japanese 32.2 KB
2024-08-08 08:01
Report Publication Announcement
確認書
Japanese 7.9 KB
2024-08-08 08:00
Interim Report
半期報告書-第25期(2024/01/01-2024/12/31)
Japanese 234.6 KB
2024-06-14 08:02
Share Issue/Capital Change
訂正臨時報告書
Japanese 35.9 KB
2024-06-14 08:01
Share Issue/Capital Change
訂正臨時報告書
Japanese 35.0 KB
2024-05-30 08:02
Share Issue/Capital Change
訂正臨時報告書
Japanese 35.5 KB
2024-05-30 08:01
Share Issue/Capital Change
臨時報告書
Japanese 30.2 KB

Automate Your Workflow. Get a real-time feed of all Adways Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Adways Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Adways Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Celyad Oncology SA Logo
Clinical-stage biotech developing CAR T therapies for solid and blood cancers.
Belgium
CYAD
CENTAUR MEDIA PLC Logo
Provides business intelligence, learning, and consultancy for marketing & legal professionals.
United Kingdom
CAU
Century Therapeutics, Inc. Logo
Developing iPSC-derived, off-the-shelf cell therapies for cancer & autoimmune diseases.
United States of America
IPSC
Cereno Scientific AB Logo
Develops epigenetic therapies for rare cardiovascular and pulmonary diseases.
Sweden
CRNO
CERES INC. Logo
Develops online media platforms connecting consumers with advertisers through a rewards system.
Japan
3696
Certara, Inc. Logo
Accelerating new medicines with biosimulation software and services for pharma & biotech.
United States of America
CERT
CEVA INC Logo
Licensor of DSP, AI, wireless, and sensing IP for low-power, smart edge devices.
United States of America
CEVA
Chabiotech Co.,Ltd. Logo
Develops cell/gene therapies and offers CDMO, biobanking, and genomics services for rare diseases.
South Korea
085660
An Ad-Tech firm providing digital marketing, SEO, social media, and creative ad solutions.
South Korea
351870
CHAMPIONS ONCOLOGY, INC. Logo
Oncology CRO accelerating drug development with PDX models and multi-omic data analytics.
United States of America
CSBR

Talk to a Data Expert

Have a question? We'll get back to you promptly.